Aldosterone-Related Cardiovascular Disease and Benefits of Mineralocorticoid Receptor Antagonists in Clinical...

Area of Science:

• Cardiovascular Medicine
• Endocrinology
• Molecular Biology

Background:

• Elevated aldosterone is linked to cardiovascular remodeling, fibrosis, endothelial dysfunction, and increased mortality.
• Mineralocorticoid receptor antagonists (MRAs) are established treatments for hypertension, heart failure, and chronic kidney disease.
• The precise molecular mechanisms of aldosterone-induced cardiac remodeling remain incompletely understood.

Purpose of the Study:

• To review existing literature on excessive aldosterone signaling in cardiovascular disease.
• To elucidate the morphostructural and molecular pathways involved in aldosterone-induced myocardial damage.
• To highlight the clinical role of MRAs in managing aldosterone-related cardiovascular conditions.

Main Methods:

• Literature review of studies investigating aldosterone's cardiovascular effects.
• Analysis of molecular pathways including oxidative stress, mitochondrial dysfunction, and ion/water retention.
• Examination of signaling pathways like G protein-coupled receptor kinase 5.
• Review of clinical data on MRA efficacy.

Main Results:

• Aldosterone promotes reactive oxygen species, oxidative stress, and mitochondrial dysfunction.
• Aldosterone induces myocardial hypertrophy via increased sarcomere mass and specific signaling pathways.
• Ion and water retention, regulated by aquaporins, contributes to aldosterone's detrimental effects.
• MRAs demonstrate clinical utility in managing conditions associated with excessive aldosterone.

Conclusions:

• Excessive aldosterone signaling is a significant driver of cardiovascular damage through multiple molecular pathways.
• Understanding these pathways provides targets for therapeutic intervention.
• MRAs are crucial in mitigating the adverse cardiovascular effects of aldosterone excess.